RCSI research into bowel cancer drugs to have impact on tailored patient treatments

Drug development and the cost of treatments to health care funders also impacted by findings Researchers in RCSI (Royal College of Surgeons in Ireland) have conducted further in-depth research to predict how patients with bowel (colorectal) cancer will respond effectively to chemotherapy, to ensure that patients will get the most suitable type of treatment from […]

Read More